Globus Medical Enters International Market with ExcelsiusGPS® Robotic Guidance and Navigation System
December 06 2018 - 4:30PM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, recently announced the entrance of
ExcelsiusGPS®, a revolutionary robotic guidance and navigation
system, to the international market with system installations
completed in several European countries. This past October, the
first European Excelsius GPS® procedure was performed at the
Metropolitan Hospital in Neo Faliro, Athens, Greece by Mr.
Panagiotis E. Zoumpoulis. Since then, numerous open and minimally
invasive spine procedures have been performed at Bonifatius
Hospital in Germany and at the Fornaca Clinic in Italy.
“Surgeons and hospital administrators in the
United States have shown tremendous levels of interest in
ExcelsiusGPS® since it first launched domestically at the end of
2017,” said Dave Demski, Chief Executive Officer at Globus Medical.
“Users have realized the system’s ability to help advance patient
care and provide tangible benefits for surgeons and their staff. As
we begin to scale our efforts abroad, we have seen similar levels
of enthusiasm within the international surgeon community and look
forward to the continued adoption of ExcelsiusGPS® into these
markets.”
Italy’s first surgeries were performed by Prof.
Franco Benech, and Dr. Carlo Alberto Benech, from Benech
Neurosurgery and Spine Specialists in Turin, Italy at the Fornaca
Clinic. “With the addition of ExcelsiusGPS® we now offer patients
seeking spine surgery a level of accuracy that was not possible
without this technology,” said Prof. Benech. “Our team is committed
to providing the highest level of care to our patients by offering
the latest advancements in robotic-assisted spine surgery at our
facilities.”
Professor Peter Douglas Klassen with Bonifatius
Hospital in Lingen, Germany echoes a similar sentiment, commenting,
“ExcelsiusGPS® is truly a revolutionary technology designed to
improve surgeon wellness and patient care. We are excited about the
potential impact that robotic guidance and navigation may have in
improving screw placement accuracy, MIS efficiency, and reducing
radiation exposure.”
About Globus Medical,
Inc.Globus Medical, Inc. is a leading musculoskeletal
solutions company based in Audubon, PA. The company was founded in
2003 by an experienced team of professionals with a shared vision
to create products that enable surgeons to promote healing in
patients with musculoskeletal disorders. Additional information can
be accessed at http://www.globusmedical.com.
Safe Harbor StatementsAll
statements included in this press release other than statements of
historical fact are forward-looking statements and may be
identified by their use of words such as “believe,” “may,” “might,”
“could,” “will,” “aim,” “estimate,” “continue,” “anticipate,”
“intend,” “expect,” “plan” and other similar terms. These
forward-looking statements are based on our current assumptions,
expectations and estimates of future events and trends.
Forward-looking statements are only predictions and are subject to
many risks, uncertainties and other factors that may affect our
businesses and operations and could cause actual results to differ
materially from those predicted. These risks and uncertainties
include, but are not limited to, factors affecting our quarterly
results, our ability to manage our growth, our ability to sustain
our profitability, demand for our products, our ability to compete
successfully (including without limitation our ability to convince
surgeons to use our products and our ability to attract and retain
sales and other personnel), our ability to rapidly develop and
introduce new products, our ability to develop and execute on
successful business strategies, our ability to comply with changing
laws and regulations that are applicable to our businesses, our
ability to safeguard our intellectual property, our success in
defending legal proceedings brought against us, trends in the
medical device industry, general economic conditions, and other
risks. For a discussion of these and other risks, uncertainties and
other factors that could affect our results, you should refer to
the disclosure contained in our most recent annual report on Form
10-K filed with the Securities and Exchange Commission, including
the sections labeled “Risk Factors” and “Cautionary Note Concerning
Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and
other filings with the Securities and Exchange Commission. These
documents are available at www.sec.gov. Moreover, we operate in an
evolving environment. New risk factors and uncertainties emerge
from time to time and it is not possible for us to predict all risk
factors and uncertainties, nor can we assess the impact of all
factors on its business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements.
Given these risks and uncertainties, readers are cautioned not to
place undue reliance on any forward-looking statements.
Forward-looking statements contained in this press release speak
only as of the date of this press release. We undertake no
obligation to update any forward-looking statements as a result of
new information, events or circumstances or other factors arising
or coming to our attention after the date hereof.
Contact:Brian KearnsVice
President, Business Development and Investor RelationsPhone: (610)
930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Sep 2023 to Sep 2024